April 7 (Reuters) - Anatara Lifesciences Ltd ANR.AX :
* CONTINUE TO ADVANCE LICENSING TALKS WITH POTENTIAL ANIMAL HEALTH PARTNERS FOR CORE ANIMAL ASSET, DETACH
* AT CURRENT TIME, ANTICIPATES DELAY, TO SECOND HALF OF 2020, FOR COMMENCEMENT OF ITS CLINICAL TRIAL IN IRRITABLE BOWEL SYNDROME
* DO NOT ANTICIPATE A MATERIAL DELAY OF MEETING PARTNERING MILESTONE FOR CORE ANIMAL ASSET DUE TO COVID-19
* AIM OF MEETING PARTNERING MILESTONE OF END Q2 FOR CORE ANIMAL ASSET, DETACH